First, because of the overactivation of the TLR4-TNF-NFκB signaling pathway, many studies have shown that TLR4 is one of the core factors of NEC, and after inhibiting the expression of TLR4-TNF-NFκB, intestinal inflammation in NEC patients is relieved [28]. This evidence concerns the gene NFKB1 and necrotizing enterocolitis.